Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response—a prospective, single-arm study

MLA

Maryam Barkhordar, et al. “Three Doses of a Recombinant Conjugated SARS-CoV-2 Vaccine Early after Allogeneic Hematopoietic Stem Cell Transplantation: Predicting Indicators of a High Serologic Response—a Prospective, Single-Arm Study.” Frontiers in Immunology, vol. 14, Apr. 2023. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1169666.

APA

Maryam Barkhordar, Bahram Chahardouli, Alireza Biglari, Mohammad Ahmadvand, Tanaz Bahri, Farshid Alaeddini, Leyla Sharifi Aliabadi, Seied Saeid Noorani, Fahimeh Bagheri Amiri, Mohammad Biglari, Mohammad Reza Shemshadi, Ardeshir Ghavamzadeh, & Mohammad Vaezi. (2023). Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response—a prospective, single-arm study. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1169666

Chicago

Maryam Barkhordar, Bahram Chahardouli, Alireza Biglari, Mohammad Ahmadvand, Tanaz Bahri, Farshid Alaeddini, Leyla Sharifi Aliabadi, et al. 2023. “Three Doses of a Recombinant Conjugated SARS-CoV-2 Vaccine Early after Allogeneic Hematopoietic Stem Cell Transplantation: Predicting Indicators of a High Serologic Response—a Prospective, Single-Arm Study.” Frontiers in Immunology 14 (April). doi:10.3389/fimmu.2023.1169666.